Get started
Live feed
·
INSIDERFilingvia Quantisnow
PDS Biotechnology Corporation logo

PDSB: SEC Form 4 filed by PDS Biotechnology Corporation

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Full content unavailable. See the original source below.

Historical context for PDSB

Across the 23 sessions after earlier PDSB headlines, the stock closed higher 14 times and lower 8 times, with a median move of 7.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

PDSB close-to-close change in the session after earlier headlines
SessionEarlier headlinePDSBSPY
Oct 20, 2026PDS Biotechnology Appoints Three Accomplished Pharma Industry Executives to Board of Directors+4.8%+0.3%
Oct 6, 2026PDS Biotech to Host Key Opinion Leader Event on PDS0301 for the Treatment of Advanced Colorectal Cancer with Liver Metastases-12.9%+0.5%
Sep 22, 2026PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncology+8.1%-0.0%
Sep 8, 2026PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks+36.4%-0.5%
Aug 13, 2026PDS Biotech Reports Second Quarter 2026 Financial Results-3.6%+0.7%
Aug 11, 2026PDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101-64.9%-0.3%

Earlier insider filings at PDSB

Quantisnow market dataNASDAQ
PDS Biotechnology Corporation logo
PDSB
PDS Biotechnology Corporation
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2015
Get push alerts for PDSB

Follow PDSB and get a push notification the moment its next story breaks.

Full PDSB profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PDSB (PDS Biotechnology Corporation) and more on Quantisnow.